• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Studies on time-kill kinetics of different classes of antibiotics against veterinary pathogenic bacteria including Pasteurella, Actinobacillus and Escherichia coli.

作者信息

Norcia L J, Silvia A M, Hayashi S F

机构信息

Pfizer Inc, Central Research Division, Groton, CT 06340, USA.

出版信息

J Antibiot (Tokyo). 1999 Jan;52(1):52-60. doi: 10.7164/antibiotics.52.52.

DOI:10.7164/antibiotics.52.52
PMID:10092198
Abstract

A systematic analysis of the bacteriostatic/bactericidal effect of several antibiotics used in veterinary medicine was carried out by time-kill kinetic analysis using P. haemolytica, P. multocida, A. pleuropneumoniae, and E. coli. The antibiotics tested were enrofloxacin, danofloxacin, erythromycin, tilmicosin, penicillin G, ceftiofur and tetracycline. Unexpectedly, the antibiotics well characterized as bacteriostatic agents against human pathogens such as tetracycline and macrolides, showed bactericidal activity against P. haemolytica and A. pleuropneumoniae. In contrast, tetracycline and erythromycin were bacteriostatic and tilmicosin was bactericidal against P. multocida. In addition, P. multocida was killed by fluoroquinolones at a slower rate than the other bacteria. Spectrum analysis revealed that ceftiofur and tilmicosin were good substrates of the universal efflux pump, AcrA/B, but penicillin and tetracycline were not. The fluoroquinolones were modest substrates for AcrA/B.

摘要

相似文献

1
Studies on time-kill kinetics of different classes of antibiotics against veterinary pathogenic bacteria including Pasteurella, Actinobacillus and Escherichia coli.
J Antibiot (Tokyo). 1999 Jan;52(1):52-60. doi: 10.7164/antibiotics.52.52.
2
In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use.新型大环内酯类药物CP - 163,505用于动物健康特定用途的体外微生物学特性研究
J Antibiot (Tokyo). 1998 Feb;51(2):136-44. doi: 10.7164/antibiotics.51.136.
3
In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens.一种新型氮杂内酯、两种三酰胺和一种氮杂内酯缩酮对牛和猪呼吸道病原体的体外微生物学特性研究
J Antibiot (Tokyo). 2004 Apr;57(4):280-8. doi: 10.7164/antibiotics.57.280.
4
Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study.欧洲患病牛和猪呼吸道病原体的抗菌药物敏感性监测:兽医病理学研究(VetPath研究)
Vet Microbiol. 2014 Aug 6;172(1-2):202-15. doi: 10.1016/j.vetmic.2014.04.008. Epub 2014 Apr 21.
5
Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.通过药代动力学/药效学建模预测猪肺炎病原体胸膜肺炎放线杆菌和多杀性巴氏杆菌的马波沙星剂量
BMC Vet Res. 2017 Jul 1;13(1):209. doi: 10.1186/s12917-017-1128-y.
6
In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin.所选兽医细菌病原体对环丙沙星、恩诺沙星和诺氟沙星的体外敏感性
Can J Vet Res. 1990 Jan;54(1):195-7.
7
Biofilm bacteria: formation and comparative susceptibility to antibiotics.生物膜细菌:形成及对抗生素的敏感性比较
Can J Vet Res. 2002 Apr;66(2):86-92.
8
Antimicrobial Resistance of , , and Isolated from Romanian Swine Farms.从罗马尼亚猪场分离出的[具体微生物名称未给出]、[具体微生物名称未给出]和[具体微生物名称未给出]的抗菌药物耐药性
Microorganisms. 2023 Sep 27;11(10):2410. doi: 10.3390/microorganisms11102410.
9
Antimicrobial susceptibility and resistance of chicken Escherichia coli, Salmonella spp., and Pasteurella multocida isolates.鸡源大肠杆菌、沙门氏菌属和多杀性巴氏杆菌分离株的药敏性与耐药性
Avian Dis. 2009 Mar;53(1):89-93. doi: 10.1637/8268-021608-Reg.1.
10
Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella choleraesuis isolates from pigs.从猪身上分离出的胸膜肺炎放线杆菌、多杀性巴氏杆菌和猪霍乱沙门氏菌菌株的抗菌药敏性。
Vet Rec. 1994 Jan 1;134(1):5-7. doi: 10.1136/vr.134.1.5.

引用本文的文献

1
Mating Assay: Plating Below a Cell Density Threshold is Required for Unbiased Estimation of Plasmid Conjugation Frequency of RP4 Transfer Between E. coli Strains.交配实验:在低于细胞密度阈值下进行平板培养,是对大肠杆菌菌株之间 RP4 转移质粒转导频率进行无偏估计所必需的。
Microb Ecol. 2024 Aug 28;87(1):109. doi: 10.1007/s00248-024-02427-7.
2
A Model to Investigate the Impact of Farm Practice on Antimicrobial Resistance in UK Dairy Farms.研究农场实践对英国奶牛场抗生素耐药性影响的模型。
Bull Math Biol. 2021 Mar 1;83(4):36. doi: 10.1007/s11538-021-00865-9.
3
A long-distance rRNA base pair impacts the ability of macrolide antibiotics to kill bacteria.
长距离 rRNA 碱基对影响大环内酯类抗生素杀死细菌的能力。
Proc Natl Acad Sci U S A. 2020 Jan 28;117(4):1971-1975. doi: 10.1073/pnas.1918948117. Epub 2020 Jan 13.
4
Monte Carlo Simulations Suggest Current Chlortetracycline Drug-Residue Based Withdrawal Periods Would Not Control Antimicrobial Resistance Dissemination from Feedlot to Slaughterhouse.蒙特卡洛模拟表明,基于当前金霉素药物残留的休药期无法控制抗菌药物耐药性从饲养场到屠宰场的传播。
Front Microbiol. 2017 Sep 20;8:1753. doi: 10.3389/fmicb.2017.01753. eCollection 2017.
5
Tetracycline Antibiotics and Resistance.四环素类抗生素与耐药性
Cold Spring Harb Perspect Med. 2016 Apr 1;6(4):a025387. doi: 10.1101/cshperspect.a025387.
6
Dissemination and characterization of plasmids carrying oqxAB-bla CTX-M genes in Escherichia coli isolates from food-producing animals.食源性动物源大肠杆菌中携带 oqxAB-bla CTX-M 基因的质粒的传播与特征。
PLoS One. 2013 Sep 9;8(9):e73947. doi: 10.1371/journal.pone.0073947. eCollection 2013.
7
Preparation and evaluation of danofloxacin mesylate microspheres and its pharmacokinetics in pigs.甲磺酸达氟沙星微球的制备与评价及其在猪体内的药代动力学研究。
Vet Res Commun. 2009 Dec;33(8):1013-22. doi: 10.1007/s11259-009-9320-6. Epub 2009 Sep 23.
8
Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica.两种给药方案对感染溶血曼氏杆菌(溶血巴斯德菌)的犊牛使用达氟沙星后的药代动力学和药效学特征
Antimicrob Agents Chemother. 2002 Sep;46(9):3013-9. doi: 10.1128/AAC.46.9.3013-3019.2002.